Pharmaceuticals discovered with AI
EFFICIENT DRUG DISCOVERY
twoXAR Pharmaceuticals has built a development portfolio targeting more than 18 different diseases. twoXAR’s unique approach to drug discovery combines steps from the traditional multi-step approach to R&D that severely limits the pace of drug discovery. This novel method – coupled with the company’s proprietary AI-driven platform – enables twoXAR to select a disease and initiate in vivo testing in months, instead of years.
The Applications of AI in Drug Discovery
twoXAR Corporate Seminar
July 19, 2019
LATEST NEWS
LATEST EVENTS
Xconomy: Xcelerating Life Sciences San Francisco
San Francisco, CA (DIGITAL EVENT)
June 25, 2020
twoXAR Pharmaceuticals CEO, Andrew A. Radin, joins a panel on "What's Next: Investment, Partnerships, and Pushing Life Sciences Forward"
Digital Meeting
June 8-12, 2020
twoXAR Pharmaceuticals CEO Andrew A. Radin describes how the company approaches drug discovery.
Digital
May 19, 2020
twoXAR Pharmaceuticals VP Discovery, Aaron Daugherty, joins DrugBank CEO Michael Wilson in an online fireside chat on using DrugBank data sources for drug discovery.
© 2020 twoXAR, Incorporated | All Rights Reserved